Trifluridine/ Tipiracil Plus Panitumumab Versus Trifluridine/ Tipiracil Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer

Clinical trial NCT05007132 · RECRUITING

Trial details

NCT number: NCT05007132
Sponsor: Dominik Paul Modest
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2021-12-17
Primary completion: 2029-12-01
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.